Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (Health Technology Assessment)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 11, June 2012].


The purpose of this Health Technology Assessment was to review and update guidance to the NHS in England and Wales on the clinical effectiveness and cost-effectiveness of the acetylcholinesterase inhibitors (AChEIs) donepezil, galantamine, rivastigmine for the Treatment of Alzheimer’s Disease (AD). It found a clinical benefit from AChEIs in alleviating AD symptoms. There is also evidence on the effectiveness of memantine, but this is less supportive than the evidence for AChEIs.

Full Text Link


Bond, M. Rogers, G. Peters, J. [et al]. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technology Assessment. April 2012; 16(21): 1-470. There is also an Executive Summary.

Health Technology Assessment in the UK (The Lancet)

The following review examines the UK’s Health Technology Assessment programme, which is 20 years old in 2013.

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).


Raftery, J. [and] Powell, J. (2013). Health technology assessment in the UK. The Lancet, October 12th 2013, 382(9900), 1278-1285.

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NHS, NIHR, Pharmacological Treatments, Proposed for Next Newsletter, Systematic Reviews, UK and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.